EUVIMEDEUVIMED entdecken
Crossref

6‐aryloxy‐2‐aminopyrimidine‐benzonitrile hybrids as anti‐infective agents: Synthesis, bioevaluation, and molecular docking

Abburi Naga Pranathi, Nagineni Devendra, Rakesh K Bollikanda, Pavan K Bangalore, Iana L Esaulkova, Mikhail G Mikhalsky, Maria A Niukalova, Vladimir V Zarubaev, Balasubramanian Sridhar, Srinivas Kantevari

Archiv der Pharmazie · 2025

DOI: 10.1002/ardp.202400580 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archiv der Pharmazie, 2025. Verfasst von Abburi Naga Pranathi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Fluoro & Agro Chemicals Division, CSIR-Indian Institute of Chemical Technology, Hyderabad, Telangana, India. Hauptthemen laut MEDLINE: Pyrimidines, Nitriles, Molecular Docking Simulation, Microbial Sensitivity Tests. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Council of Scientific and industrial Research (CSIR), DST-INSPIRE.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This report explores the potential of novel 6‐aryloxy‐2‐aminopyrimidine‐benzonitrile scaffolds as promising anti‐infective agents in the face of the increasing threat of infectious diseases. Starting from 2‐amino‐4,6‐dichloropyrimidine, a series of 24 compounds inspired from the antiviral drugs dapivirine, etravirine, and rilpivirine were designed and synthesized via a two‐step reaction sequence in good yields. Biological testing of synthetic analogs revealed potent inhibition against both viral and tuberculosis targets. Notably, compounds 5p (2,4‐dimethyl substitution; IC 50 = 44 ± 4.9 µM; selectivity index [SI] = 20) and 5 s (3‐thiophenphenyl; IC 50 = 6 ± 1 µM; SI = 120) showed significant antiviral activity against pandemic influenza virus A/Puerto Rico/8/34 (H1N1) with positive toxicity profiles and also exhibited good IC 50 values ( 5p , IC 50 = 10 ± 2 µM; SI = 9 and 5 s , IC 50 = 16 ± 2 µM; SI = 60) against the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) (Wuhan strain) compared with favipiravir. In addition, analogs 5a , 5r , 5t , and 5u showed good antitubercular activity against Mycobacterium tuberculosis H37Rv strain and compounds 3 , 5f , 5n , and 5q showed moderate antibacterial activity against gram+ve and gram‐ve bacterial strains, suggesting that this scaffold has a broad spectrum of therapeutic effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyrimidinesNitrilesMolecular Docking SimulationMicrobial Sensitivity TestsAntiviral AgentsStructure-Activity RelationshipHumansMolecular StructureInfluenza A Virus, H1N1 SubtypeMycobacterium tuberculosisAnti-Infective AgentsDose-Response Relationship, DrugAnimalsAnti-Bacterial AgentsAntitubercular Agents

Stichwörter der Autor:innen

2‐aminopyrimidineantimicrobialantitubercularantiviralmolecular docking

Substanzen

PyrimidinesNitrilesAntiviral Agentsbenzonitrile2-aminopyrimidineAnti-Infective AgentsAnti-Bacterial AgentsAntitubercular Agents

Autor:innen und Institutionen

  • Fluoro & Agro Chemicals Division, CSIR-Indian Institute of Chemical Technology, Hyderabad, Telangana, India.
  • Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India.
  • Pasteur Institute of Epidemiology and Microbiology, St. Petersburg, Russia.
  • Centre for X-ray Crystallography, Analytical Chemistry Division, CSIR- Indian Institute of Chemical Technology, Hyderabad, Telangana, India.

Förderung

  • Council of Scientific and industrial Research (CSIR)
  • DST-INSPIRE

Zitieren

APA

Pranathi, A. N., Devendra, N., Bollikanda, R. K., Bangalore, P. K., Esaulkova, I. L., Mikhalsky, M. G., Niukalova, M. A., Zarubaev, V. V., Sridhar, B., & Kantevari, S. (2025). 6‐aryloxy‐2‐aminopyrimidine‐benzonitrile hybrids as anti‐infective agents: Synthesis, bioevaluation, and molecular docking. Archiv der Pharmazie. https://doi.org/10.1002/ardp.202400580

Vancouver

Pranathi AN, Devendra N, Bollikanda RK, Bangalore PK, Esaulkova IL, Mikhalsky MG, et al. 6‐aryloxy‐2‐aminopyrimidine‐benzonitrile hybrids as anti‐infective agents: Synthesis, bioevaluation, and molecular docking. Archiv der Pharmazie. 2025. doi:10.1002/ardp.202400580

BibTeX
@article{Pranathi2025,
  author = {Pranathi, Abburi Naga and Devendra, Nagineni and Bollikanda, Rakesh K and Bangalore, Pavan K and Esaulkova, Iana L and Mikhalsky, Mikhail G and Niukalova, Maria A and Zarubaev, Vladimir V and Sridhar, Balasubramanian and Kantevari, Srinivas},
  title = {6‐aryloxy‐2‐aminopyrimidine‐benzonitrile hybrids as anti‐infective agents: Synthesis, bioevaluation, and molecular docking},
  journal = {Archiv der Pharmazie},
  year = {2025},
  doi = {10.1002/ardp.202400580}
}
Kostenlos starten →